These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3830774)

  • 21. In vitro activity of rosaramicin against Chlamydia trachomatis.
    Bowie WR
    Antimicrob Agents Chemother; 1980 Dec; 18(6):978-9. PubMed ID: 7235684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin.
    Smith TF; Washton HE
    Antimicrob Agents Chemother; 1978 Sep; 14(3):493-4. PubMed ID: 708027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Action of ++clarithromycin against mycoplasma and chlamydia].
    Franzoso G; Cusinato R; Tonin EA; Meloni GA
    G Ital Chemioter; 1991; 38(1-3):159-61. PubMed ID: 1365578
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of men with urethritis negative for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum.
    Maeda S; Tamaki M; Kubota Y; Nguyen PB; Yasuda M; Deguchi T
    Int J Urol; 2007 May; 14(5):422-5. PubMed ID: 17511725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosaramicin and tetracycline in the treatment of non-gonococcal urethritis. A comparison of clinical and microbiological results.
    Darne JF; Ridgway GL; Oriel JD
    Br J Vener Dis; 1982 Apr; 58(2):117-20. PubMed ID: 7039760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activity of roxithromycin against Chlamydia trachomatis.
    Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
    J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of tiamulin against bovine respiratory tract mycoplasmas.
    Allan EM; Pirie HM
    Res Vet Sci; 1981 Sep; 31(2):174-6. PubMed ID: 7323463
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.
    Wang SA; Papp JR; Stamm WE; Peeling RW; Martin DH; Holmes KK
    J Infect Dis; 2005 Mar; 191(6):917-23. PubMed ID: 15717267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of a novel polyherbal formulation BASANT for prevention of Chlamydia trachomatis infection.
    Bhengraj AR; Dar SA; Talwar GP; Mittal A
    Int J Antimicrob Agents; 2008 Jul; 32(1):84-8. PubMed ID: 18524545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains.
    Palù G; Valisena S; Barile MF; Meloni GA
    Eur J Epidemiol; 1989 Jun; 5(2):146-53. PubMed ID: 2767221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on activities of eight kinds of traditional Chinese medicine against urogential Chlamydia trachomatis].
    Li J; Tu Y; Tong J; Wang P
    Zhong Yao Cai; 1999 Aug; 22(8):414-5. PubMed ID: 12571890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
    Bai H; Dong J; Ning B
    Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incidence of Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma species, Streptococci of the Lancefield group B and Candida species in newborn infants during the first week of life].
    Martius J; Wecker I; Hartmann AA
    Z Geburtshilfe Perinatol; 1983; 187(5):235-8. PubMed ID: 6685946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Chlamydia trachomatis and Mycoplasma hominis, genitalium and Ureaplasma urealyticum by polymerase chain reaction in patients with sterile pyuria.
    Nassar FA; Abu-Elamreen FH; Shubair ME; Sharif FA
    Adv Med Sci; 2008; 53(1):80-6. PubMed ID: 18614434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.
    García-Castillo M; Morosini MI; Gálvez M; Baquero F; del Campo R; Meseguer MA
    J Antimicrob Chemother; 2008 Nov; 62(5):1027-30. PubMed ID: 18753188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activity of a new quinoline derivative against Chlamydia trachomatis].
    Mitsui Y; Higashitsutsumi M
    Nippon Ganka Gakkai Zasshi; 1986 Aug; 90(8):1074-80. PubMed ID: 3464167
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
    Catalan F; Milovanovic A; Prouteau C; Soulignac M
    Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The static effect of rosaramicin on Ureaplasma urealyticum and the development of antibiotic resistance.
    Taylor-Robinson D; Furr PM
    J Antimicrob Chemother; 1982 Sep; 10(3):185-91. PubMed ID: 7142072
    [No Abstract]   [Full Text] [Related]  

  • 39. Erythromycin treatment of acute and chronic urethritis, prostatitis and colpitis caused by Ureaplasma urealyticum and Chlamydia trachomatis.
    Blenk H; Blenk B; Deimann E
    J Int Med Res; 1980; 8 Suppl 2():59-63. PubMed ID: 7429007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium in semen and first void urine specimens of asymptomatic male partners of infertile couples.
    Gdoura R; Kchaou W; Ammar-Keskes L; Chakroun N; Sellemi A; Znazen A; Rebai T; Hammami A
    J Androl; 2008; 29(2):198-206. PubMed ID: 18077823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.